Exact Mass: 427.2634916

Exact Mass Matches: 427.2634916

Found 48 metabolites which its exact mass value is equals to given mass value 427.2634916, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Pimavanserin

Urea, N-((4-fluorophenyl)methyl)-N-(1-methyl-4-piperidinyl)-n-((4-(2-methylpropoxy)phenyl)methyl)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1)

C25H34FN3O2 (427.2634916)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Pimavanserin is a selective inverse agonist of the 5-HT2A receptor with pIC50 and pKd of 8.73 and 9.3, respectively.

   

arginylprolylarginine

arginylprolylarginine

C17H33N9O4 (427.2655378)


   

Gly Pro Arg Val

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C18H33N7O5 (427.2543048)


   

Gly Pro Val Arg

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C18H33N7O5 (427.2543048)


   

Gly Arg Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C18H33N7O5 (427.2543048)


   

Gly Arg Val Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C18H33N7O5 (427.2543048)


   

Gly Val Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C18H33N7O5 (427.2543048)


   

Gly Val Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C18H33N7O5 (427.2543048)


   

Pro Arg Arg

Pro Arg Arg

C17H33N9O4 (427.2655378)


   

Arg Arg Pro

Arg Arg Pro

C17H33N9O4 (427.2655378)


   

Arg Pro Arg

Arg Pro Arg

C17H33N9O4 (427.2655378)


   

Pro Gly Arg Val

(2S)-2-[(2S)-5-carbamimidamido-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}pentanamido]-3-methylbutanoic acid

C18H33N7O5 (427.2543048)


   

Pro Gly Val Arg

(2S)-5-carbamimidamido-2-[(2S)-3-methyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanamido]pentanoic acid

C18H33N7O5 (427.2543048)


   

Pro Arg Gly Val

(2S)-2-{2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]acetamido}-3-methylbutanoic acid

C18H33N7O5 (427.2543048)


   

Pro Arg Val Gly

2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-methylbutanamido]acetic acid

C18H33N7O5 (427.2543048)


   

Pro Val Gly Arg

(2S)-5-carbamimidamido-2-{2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetamido}pentanoic acid

C18H33N7O5 (427.2543048)


   

Pro Val Arg Gly

2-[(2S)-5-carbamimidamido-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]pentanamido]acetic acid

C18H33N7O5 (427.2543048)


   

Arg Gly Pro Val

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetyl}pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C18H33N7O5 (427.2543048)


   

Arg Gly Val Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C18H33N7O5 (427.2543048)


   

Arg Pro Gly Val

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-methylbutanoic acid

C18H33N7O5 (427.2543048)


   

Arg Pro Val Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]acetic acid

C18H33N7O5 (427.2543048)


   

Arg Val Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]acetyl}pyrrolidine-2-carboxylic acid

C18H33N7O5 (427.2543048)


   

Arg Val Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}acetic acid

C18H33N7O5 (427.2543048)


   

Val Gly Pro Arg

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-methylbutanamido]acetyl}pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C18H33N7O5 (427.2543048)


   

Val Gly Arg Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C18H33N7O5 (427.2543048)


   

Val Pro Gly Arg

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}acetamido)-5-carbamimidamidopentanoic acid

C18H33N7O5 (427.2543048)


   

Val Pro Arg Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]acetic acid

C18H33N7O5 (427.2543048)


   

Val Arg Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]acetyl}pyrrolidine-2-carboxylic acid

C18H33N7O5 (427.2543048)


   

Val Arg Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}acetic acid

C18H33N7O5 (427.2543048)


   

cyclopropyl amide

N-ethyl-9α,11α,15S-trihydroxy-17-phenyl-18,19,20-trinor-prosta-5Z,13E-dien-1-cyclopropyl amide

C26H37NO4 (427.27224420000005)


   

bis[tris(dimethylamino)-λ5-phosphanylidene]azanium,tetrafluoroborate

bis[tris(dimethylamino)-λ5-phosphanylidene]azanium,tetrafluoroborate

C12H36BF4N7P2 (427.25364740000003)


   

sodium 2-[methyl(1-oxooctadecyl)amino]ethanesulphonate

sodium 2-[methyl(1-oxooctadecyl)amino]ethanesulphonate

C21H42NNaO4S (427.2732092000001)


   

(2S,3R)-2-[[4-(tert-butylcarbamoyl)piperazine-1-carbonyl]amino]-6-(diaminomethylideneamino)-3-formylhexanoic acid

(2S,3R)-2-[[4-(tert-butylcarbamoyl)piperazine-1-carbonyl]amino]-6-(diaminomethylideneamino)-3-formylhexanoic acid

C18H33N7O5 (427.2543048)


   

2-[4-[1-(2-Fluorophenyl)-4-piperidinyl]-1-[(3-methoxyphenyl)methyl]-2-piperazinyl]ethanol

2-[4-[1-(2-Fluorophenyl)-4-piperidinyl]-1-[(3-methoxyphenyl)methyl]-2-piperazinyl]ethanol

C25H34FN3O2 (427.2634916)


   

(2S)-2-[[(2S)-1-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid

(2S)-2-[[(2S)-1-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid

C17H33N9O4 (427.2655378)


   

N-Benzylidene-1-amino(hepta)ethyleneglycol monomethyl ether

N-Benzylidene-1-amino(hepta)ethyleneglycol monomethyl ether

C22H37NO7 (427.2569892)


   

Pro-Arg-Arg

Pro-Arg-Arg

C17H33N9O4 (427.2655378)


   

Arg-Arg-Pro

Arg-Arg-Pro

C17H33N9O4 (427.2655378)


   

Pimavanserin

Pimavanserin

C25H34FN3O2 (427.2634916)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Pimavanserin is a selective inverse agonist of the 5-HT2A receptor with pIC50 and pKd of 8.73 and 9.3, respectively.

   

MGCC 12:3

MGCC 12:3

C22H37NO7 (427.2569892)


   

Arg-Pro-Arg

Arg-Pro-Arg

C17H33N9O4 (427.2655378)


   

ST 20:0;O5;Gly

ST 20:0;O5;Gly

C22H37NO7 (427.2569892)


   

ST 24:4;O2;Gly

ST 24:4;O2;Gly

C26H37NO4 (427.27224420000005)


   

n-[(2r,3r,4r,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-{[(1s,4r)-1-methyl-4-[(2s)-6-oxoheptan-2-yl]cyclohex-2-en-1-yl]oxy}oxan-3-yl]ethanimidic acid

n-[(2r,3r,4r,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-{[(1s,4r)-1-methyl-4-[(2s)-6-oxoheptan-2-yl]cyclohex-2-en-1-yl]oxy}oxan-3-yl]ethanimidic acid

C22H37NO7 (427.2569892)


   

(4br,10as)-3-(2-carboxyethyl)-2-(carboxylatomethyl)-4b,7,7,10a-tetramethyl-5h,6h,6ah,8h,9h,10h,10bh,11h,12h-naphtho[2,1-f]isoquinolin-2-ium

(4br,10as)-3-(2-carboxyethyl)-2-(carboxylatomethyl)-4b,7,7,10a-tetramethyl-5h,6h,6ah,8h,9h,10h,10bh,11h,12h-naphtho[2,1-f]isoquinolin-2-ium

C26H37NO4 (427.27224420000005)


   

n-[4,5-dihydroxy-6-(hydroxymethyl)-2-{[1-methyl-4-(6-oxoheptan-2-yl)cyclohex-2-en-1-yl]oxy}oxan-3-yl]ethanimidic acid

n-[4,5-dihydroxy-6-(hydroxymethyl)-2-{[1-methyl-4-(6-oxoheptan-2-yl)cyclohex-2-en-1-yl]oxy}oxan-3-yl]ethanimidic acid

C22H37NO7 (427.2569892)


   

n-[(2s,3r,4r,5s,6r)-2-({1-[(2r,4s,4ar,8as)-4,7-dimethyl-3,4,4a,5,6,8a-hexahydro-2h-1-benzopyran-2-yl]propan-2-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid

n-[(2s,3r,4r,5s,6r)-2-({1-[(2r,4s,4ar,8as)-4,7-dimethyl-3,4,4a,5,6,8a-hexahydro-2h-1-benzopyran-2-yl]propan-2-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid

C22H37NO7 (427.2569892)


   

n-[(2s,3r,4r,5s,6r)-2-({1-[(2s,4s,4ar,8as)-4,7-dimethyl-3,4,4a,5,6,8a-hexahydro-2h-1-benzopyran-2-yl]propan-2-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid

n-[(2s,3r,4r,5s,6r)-2-({1-[(2s,4s,4ar,8as)-4,7-dimethyl-3,4,4a,5,6,8a-hexahydro-2h-1-benzopyran-2-yl]propan-2-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid

C22H37NO7 (427.2569892)